September 01, 2013
1 min read
Save

OVERCOME

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Assessment of enalapril plus carvedilol in the prevention of chemotherapy-induced left ventricular systolic dysfunction in patients with hematological malignancies.

OVERCOME